(Date:12/2/2008)...epresentatives from the fitness,company Burn Mach... Shriners,Hospitals for Children in Chicago last ...nique, cause; The Burn Machine donated more than $...ent to the first ever Shriners,Wheelchair Bodybui...com/cgi-bin/prnh/20081203/CLW007 ) , "We k...
(Date:12/2/2008)...ersity, The Brigham and Women,s Hospital (Boston),...has found a new drug with the potential to allevia...k. , Dr Shantha Rajaratnam from Monash Universi...gical Medicine said tasimelteon, a drug which acts...ighly effective treatment for circadian rhythm sle...
(Date:12/2/2008)... Reminder, the nation,s leading,comprehensive pat... industry,technology today at Javits Center in Ne...ng and distributing video testimonials can be used... popular platforms such as YouTube, Google,Videos...with an effective,business strategy for increasin...
(Date:12/2/2008)... enterprise software and online services veteran i...scribers of Yugma,s instant web conferencing solut...RWEB) December 2, 2008 -- Yugma , the leading web... collaborate instantly using the Internet, announc...utive Officer. , , ,Vas has more than 20 years of ...
Breaking Medicine News(10 mins):Health News:Burn Machine Speed Bag Knocks 'em Out at Shriners Wheelchair Bodybuilding Camp 2Health News:New medication brings hope of jet lag cure 2Health News:Doctors Go Viral: vSling Video Testimonial Tool Offers Doctors Access to New Channels for Acquiring Patients 2Health News:Doctors Go Viral: vSling Video Testimonial Tool Offers Doctors Access to New Channels for Acquiring Patients 3Health News:Yugma Appoints Vas Bhandarkar as Chief Executive Officer 2Health News:Yugma Appoints Vas Bhandarkar as Chief Executive Officer 3(Date:12/2/2008)..., Md., Dec. 2 Micromet, ...y developing novel, proprietary antibodies for the...diseases, today announced that it has entered into...cing Facility (CEFF) with Kingsbridge Capital Limi...of the agreement, Kingsbridge has committed to pro...
(Date:12/1/2008)...E, Dec. 1 S*BIO Pte Ltd today anno... of SB1518, a potent and orally-active JAK2 inhibi...atients with chronic idiopathic myelofibrosis (CIM...the safety and tolerability of SB1518 in patients ...ts. The Phase 1 part of the study will assess the...
(Date:12/1/2008)... MEETING, Pa., Dec. 1 G...ed that dosing of subjects has begun in study MSI-... Phase 1b study of trodusquemine (MSI-1436) in ove...novel therapeutic for the treatment of type 2 diab...rally to regulate insulin and leptin pathways thro...
(Date:11/30/2008)..., CHICAGO, Dec. 1 Old...rebral blood flow and a greater number of small bl...esented today at the annual meeting of the Radiolo... The study, conducted at the University of North ...ompare brain scans of older adults who exercise to...
Breaking Medicine Technology:Micromet Expands Committed Equity Financing Facility to $75 Million 2Micromet Expands Committed Equity Financing Facility to $75 Million 3Micromet Expands Committed Equity Financing Facility to $75 Million 4Micromet Expands Committed Equity Financing Facility to $75 Million 5Micromet Expands Committed Equity Financing Facility to $75 Million 6S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 2Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 3Exercise Helps Prevent Age-Related Brain Changes in Older Adults 2Exercise Helps Prevent Age-Related Brain Changes in Older Adults 3Newly Approved HIV Drug Shows Great Promise 1290 1Newly Approved HIV Drug Shows Great Promise 1290 2Penn researchers discover new target for preventing and treating flu 10555 1Penn researchers discover new target for preventing and treating flu 10555 2Center for Science Writings presents 3A Big Fat Lies 3A The Truth about Diet Exercise and Obesity 10553 1American College of Preventive Medicine calls on ABC to cancel Eli Stone episode 10551 1...NEWSWIRE) -- Discovery,Laboratories, Inc. (Nasdaq:...-up results from its SELECT and STAR Phase 3,clini...mier medical,journal for pediatric healthcare prac...STAR trials concluded that Surfaxin,demonstrated a...tive to existing animal-derived surfactants, Surva...
...l Conference on Avian,Influenza at France,s Pasteu...tCall/ -- Very low doses of,Novavax Inc.,s pandemi...lethal challenge of live H5N1 viruses, according t...cond International,Conference on Avian Influenza i...oses of Novavax,s,virus-like particle (VLP) H5N1 v...
Other Medicine Technology:Surfaxin (Lucinactant) Long-Term Survival Advantage vs. Comparators,Published in Pediatrics 2Surfaxin (Lucinactant) Long-Term Survival Advantage vs. Comparators,Published in Pediatrics 3Surfaxin (Lucinactant) Long-Term Survival Advantage vs. Comparators,Published in Pediatrics 4Surfaxin (Lucinactant) Long-Term Survival Advantage vs. Comparators,Published in Pediatrics 5Novavax Pandemic Flu Vaccine Provided Protection Against a Lethal,Challenge of Live Virus, Pre-Clinical Data Show 2Novavax Pandemic Flu Vaccine Provided Protection Against a Lethal,Challenge of Live Virus, Pre-Clinical Data Show 3Novavax Pandemic Flu Vaccine Provided Protection Against a Lethal,Challenge of Live Virus, Pre-Clinical Data Show 415 mm curved blade. 8 mm straight distal tip. Serrated on top of knife. Flat handle.
Fixed smooth rod which slides on skin. Designated most popular model or size.
For use with N4096 R, N4097 R and N4098 R. 18 mm wide x 167 mm long. Ten per package. Designated most popular model or size.
30 mm button end blade. Flat handle.
Medicine Products: